Clinical Trial Update: Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis

View source ↗

Summary

ClinicalTrials.gov update on a voriconazole inhalation powder trial for pulmonary aspergillosis; the study is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis
• Anastomotic Infection
• Aspergillus Tracheobronchitis
• Invasive Pulmonary Aspergillosis
• Pulmonary Aspergillosis
• Pulmonary Fungal Infection

Drugs mentioned

• Voriconazole Inhalation Powder (voriconazole)

Snippet

Sponsor: TFF Pharmaceuticals, Inc. | Conditions: Invasive Pulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis | Status: NO_LONGER_AVAILABLE